Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Érica Leandro Marciano Vieira is active.

Publication


Featured researches published by Érica Leandro Marciano Vieira.


Journal of Nutritional Biochemistry | 2012

Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis

Érica Leandro Marciano Vieira; Alda Jusceline Leonel; Alexandre P. Sad; Nathália R.M. Beltrão; Thaís F. Costa; Talita Mayra Ferreira; Ana Cristina Gomes-Santos; Ana Maria Caetano Faria; Maria do Carmo Gouveia Peluzio; Denise Carmona Cara; Jacqueline I. Alvarez-Leite

Butyrate is a four-carbon short-chain fatty acid that improves colonic trophism. Although several studies have shown the benefits of butyrate enemas in ulcerative colitis (UC), studies using the oral route are rare in the literature. In the present study, we evaluated the effect of butyrate intake in the immune response associated to UC. For that, mice were fed control or butyrate (0.5% sodium butyrate) diets for 14 days. Acute UC was induced by dextran sulphate sodium (DSS, 2.5%), replacing drinking water. The results showed that, in UC animals, oral butyrate significantly improved trophism and reduced leukocyte (eosinophil and neutrophil) infiltration in the colon mucosa and improved the inflammatory profile (activated macrophage, B and T lymphocytes) in cecal lymph nodes. In the small intestine, although mucosa histology was similar among groups, DSS treatment reduced duodenal transforming growth factor-β, increased interleukin-10 concentrations and increased memory T lymphocytes and dendritic cells in Peyers patches. Butyrate supplementation was able to revert these alterations. When cecal butyrate concentration was analyzed in cecal content, it was still higher in the healthy animals receiving butyrate than in the UC+butyrate and control groups. In conclusion, our results show that oral administration of sodium butyrate improves mucosa lesion and attenuates the inflammatory profile of intestinal mucosa, local draining lymph nodes and Peyers patches of DSS-induced UC. Our results also highlight the potential use of butyrate supplements as adjuvant in UC treatment.


American Journal of Pathology | 2009

Treatment with a novel chemokine-binding protein or eosinophil lineage-ablation protects mice from experimental colitis

Angélica T. Vieira; Caio T. Fagundes; Ana L. Alessandri; Marina Gomes Miranda e Castor; Rodrigo Guabiraba; Valdinéria Oliveira Borges; Kátia D. Silveira; Érica Leandro Marciano Vieira; Juliana L. Gonçalves; Tarcília Aparecida Silva; Maud Deruaz; Amanda E. I. Proudfoot; Lirlândia P. Sousa; Mauro M. Teixeira

Eosinophils are multifunctional leukocytes implicated in numerous inflammatory diseases. The present study was conducted to clarify the precise role of eosinophils in the development of colitis by using eosinophil-depleted mice and a novel chemokine-binding protein that neutralizes CCL11 action. Colitis was induced by administration of dextran sodium sulfate (DSS) to wild-type and eosinophil-deficient DeltadblGATA-1 mice. Accumulation of eosinophils in the gut of mice given DSS paralleled worsening of clinical score and weight loss. In response to DSS, DeltadblGATA-1 mice showed virtual absence of eosinophil recruitment, amelioration of clinical score, weight loss, and tissue destruction, and no lethality. There was a decrease in CXCL1 and CCL3 production and decreased neutrophil influx in the intestine of DeltadblGATA-1 mice. Transfer of bone marrow cells from wild-type mice reconstituted disease manifestation in DSS-treated DeltadblGATA-1 mice, and levels of CCL11 were increased after DSS treatment and localized to inflammatory cells. Treatment with the chemokine-binding protein evasin-4 at a dose that prevented the function of CCL11 greatly ameliorated clinical score, weight loss, overall tissue destruction, and death rates. In conclusion, the influx of eosinophils is critical for the induction of colitis by DSS. Treatment with a novel chemokine-binding protein decreased eosinophil influx and greatly ameliorated colitis, suggesting that strategies that interfere with the recruitment of eosinophils may be useful as therapy for colitis.


European Neuropsychopharmacology | 2014

BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: results from a factorial, randomized, sham-controlled trial.

Andre R. Brunoni; Rodrigo Machado-Vieira; Carlos A. Zarate; Érica Leandro Marciano Vieira; Marie-Anne Vanderhasselt; Michael A. Nitsche; Leandro Valiengo; Isabela M. Benseñor; Paulo A. Lotufo; Wagner F. Gattaz; Antônio Lúcio Teixeira

Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation intervention that modifies cortical excitability according to the stimulation parameters. Preclinical and clinical studies in healthy volunteers suggest that tDCS induces neuroplastic alterations of cortical excitability, which might explain its clinical effects in major depressive disorder (MDD). We therefore examined whether tDCS, as compared to the antidepressant sertraline, increases plasma brain-derived neurotrophic factor (BDNF) levels, a neurotrophin associated with neuroplasticity. Patients (n=73) with major depressive disorder were randomized to active/sham tDCS and sertraline/placebo (four groups) in this 6-week, double-blind, placebo-controlled trial. We measured BDNF plasma levels at baseline and endpoint, observing no significant changes of BDNF levels after treatment. In addition, no significant changes were observed in responders and non-responders as well as no relationships between BDNF levels and clinical and psychopathological variables related to depression. Thus, in one of the few placebo-controlled trials evaluating BDNF changes over an antidepressant treatment course, we did not observe BDNF increase regardless of clinical improvement in depressed patients. Regarding tDCS, BDNF plasma levels might not be a good candidate biomarker to evaluate depression improvement or be a predictor of response in patients treated with tDCS, as our results showed that BDNF increase was not necessary to induce clinical response. Finally, our findings do not support a relationship between BDNF and improvement of depression.


Movement Disorders | 2014

Plasma levels of soluble tumor necrosis factor receptors are associated with cognitive performance in Parkinson's disease.

Natália Pessoa Rocha; Antônio Lúcio Teixeira; Paula Luciana Scalzo; Izabela Guimarães Barbosa; Mariana Soares de Sousa; Isabela Boechat Morato; Érica Leandro Marciano Vieira; Paulo Pereira Christo; András Palotás; Helton José Reis

Inflammatory mechanisms have been implicated in a series of neuropsychiatric conditions, including behavioral disturbances, cognitive dysfunction, and affective disorders. Accumulating evidence also strongly suggests their involvement in the pathophysiology of Parkinsons disease (PD). This study aimed to evaluate plasma levels of inflammatory biomarkers, and their association with cognitive performance and other non‐motor symptoms of PD. PD patients and control individuals were subjected to various psychometric tests, including the Mini‐Mental State Examination (MMSE), Frontal Assessment Battery (FAB), and Becks Depression Inventory (BDI). Biomarker plasma levels were measured by enzyme‐linked immunosorbent assay (ELISA). PD patients exhibited worse performance on MMSE and the programming task of FAB, and presented higher soluble tumor necrosis factor receptor (sTNFR) plasma levels than control individuals. Among PD patients, increased sTNFR1 and sTNFR2 concentrations were associated with poorer cognitive test scores. After multiple linear regression, sTNFR1 and education remained a significant predictor for FAB scores. Our data suggest that PD is associated with a proinflammatory profile, and sTNFRs are putative biomarkers of cognitive performance, with elevated sTNFR1 levels predicting poorer executive functioning in PD patients.


Arthritis & Rheumatism | 2011

Resolution of neutrophilic inflammation by H2O2 in antigen‐induced arthritis

Fernando Lopes; Fernanda M. Coelho; Vivian V. Costa; Érica Leandro Marciano Vieira; Lirlândia P. Sousa; Tarcília Aparecida Silva; Leda Quercia Vieira; Mauro M. Teixeira; Vanessa Pinho

OBJECTIVE Neutrophil accumulation contributes to the pathogenesis of rheumatoid arthritis. This study was undertaken to examine the ability of H2O2 to influence neutrophilic inflammation in a model of antigen-induced arthritis (AIA) in mice. METHODS AIA was induced by administration of antigen into the knee joints of previously immunized mice. Neutrophil accumulation was measured by counting neutrophils in the synovial cavity and assaying myeloperoxidase activity in the tissue surrounding the mouse knee joint. Apoptosis was determined by morphologic and molecular techniques. The role of H2O2 was studied using mice that do not produce reactive oxygen species (gp91phox-/- mice) and drugs that enhance the generation or enhance the degradation of H2O2. RESULTS Antigen challenge of immunized mice induced neutrophil accumulation that peaked at 12-24 hours after challenge. H2O2 production peaked at 24 hours, after which time, the inflammation resolved. Neutrophil recruitment was similar in wild-type and gp91phox-/- mice, but there was delayed resolution in gp91phox-/- mice or after administration of catalase. In contrast, administration of H2O2 or superoxide dismutase (SOD) resolved neutrophilic inflammation. The resolution of inflammation induced by SOD or H2O2 was accompanied by an increase in the number of apoptotic neutrophils. Apoptosis was associated with an increase in Bax and caspase 3 cleavage and was secondary to phosphatidylinositol 3-kinase (PI3K)/Akt activation. CONCLUSION Our findings indicate that levels of H2O2 increase during neutrophil influx and are necessary for the natural resolution of neutrophilic inflammation. Mechanistically, enhanced levels of H2O2 (endogenous or exogenous) inhibit p-Akt/NF-κB and induce apoptosis of migrated neutrophils. Modulation of H2O2 production may represent a novel strategy for controlling neutrophilic inflammation in the joints.


Journal of Immunology | 2015

The Role and Effects of Glucocorticoid-Induced Leucine Zipper in the Context of Inflammation Resolution

Juliana P. Vago; Luciana P. Tavares; Cristiana C. Garcia; Kátia M. Lima; Luiza Oliveira Perucci; Érica Leandro Marciano Vieira; Camila R. C. Nogueira; Frederico M. Soriani; Joilson O. Martins; Patrícia M.R. e Silva; Karina Braga Gomes; Vanessa Pinho; Stefano Bruscoli; Carlo Riccardi; Elaine Beaulieu; Eric Francis Morand; Mauro M. Teixeira; Lirlândia P. Sousa

Glucocorticoid (GC)-induced leucine zipper (GILZ) has been shown to mediate or mimic several actions of GC. This study assessed the role of GILZ in self-resolving and GC-induced resolution of neutrophilic inflammation induced by LPS in mice. GILZ expression was increased during the resolution phase of LPS-induced pleurisy, especially in macrophages with resolving phenotypes. Pretreating LPS-injected mice with trans-activator of transcription peptide (TAT)–GILZ, a cell-permeable GILZ fusion protein, shortened resolution intervals and improved resolution indices. Therapeutic administration of TAT-GILZ induced inflammation resolution, decreased cytokine levels, and promoted caspase-dependent neutrophil apoptosis. TAT-GILZ also modulated the activation of the survival-controlling proteins ERK1/2, NF-κB and Mcl-1. GILZ deficiency was associated with an early increase of annexin A1 (AnxA1) and did not modify the course of neutrophil influx induced by LPS. Dexamethasone treatment resolved inflammation and induced GILZ expression that was dependent on AnxA1. Dexamethasone-induced resolution was not altered in GILZ−/− mice due to compensatory expression and action of AnxA1. Our results show that therapeutic administration of GILZ efficiently induces a proapoptotic program that promotes resolution of neutrophilic inflammation induced by LPS. Alternatively, a lack of endogenous GILZ during the resolution of inflammation is compensated by AnxA1 overexpression.


The International Journal of Neuropsychopharmacology | 2015

Monocyte and lymphocyte activation in bipolar disorder: a new piece in the puzzle of immune dysfunction in mood disorders.

Izabela Guimarães Barbosa; Natália Pessoa Rocha; Frankcinéia Assis; Érica Leandro Marciano Vieira; Jair C Soares; Moises Evandro Bauer; Antônio Lúcio Teixeira

Background: This study tested the hypothesis that the low-grade inflammation presented in patients with bipolar disorder (BD) is associated with expansion of activated T cells, and this activated state may be due to a lack of peripheral regulatory cells. Methods: Specifically, we investigated the distribution of monocytes and lymphocyte subsets, and investigated Th1/Th2/Th17 cytokines in plasma by flow cytometry. Twenty-one BD type I patients and 21 age- and sex-matched controls were recruited for this study. Results: BD patients had increased proportions of monocytes (CD14+). Regarding lymphocyte populations, BD patients presented reduced proportions of T cells (CD3+) and cytotoxic T cells (CD3+CD8+). BD patients also exhibited a higher percentage of activated T CD4+CD25+ cells, and a lower percentage of IL-10 expressing Treg cells. Conclusions: Our data shed some light into the underlying mechanisms involved with the chronic low-grade inflammatory profile described in BD patients.


Journal of Leukocyte Biology | 2011

PI3Kγ controls leukocyte recruitment, tissue injury, and lethality in a model of graft-versus-host disease in mice

Marina Gomes Miranda e Castor; Bárbara M. Rezende; Priscila T. T. Bernardes; Angélica T. Vieira; Érica Leandro Marciano Vieira; Rosa Maria Esteves Arantes; Danielle G. Souza; Tarcília Aparecida Silva; Mauro M. Teixeira; Vanessa Pinho

PI3Kγ is thought to mediate leukocyte migration to injured tissues and may be important in the pathogenesis of various T‐lymphocyte‐dependent pathologies, including autoimmune and inflammatory diseases. The present study evaluated the relevance of PI3Kγ in donor cells for the pathogenesis of acute GVHD using a model of adoptive transfer of splenocytes from WT or PI3Kγ−/− C57BL/6J mice to B6D2F1 mice, and mice that received PI3Kγ−/− cells showed reduced clinical signs of disease, bacterial translocation, tissue injury, and lethality rates. This was associated with reduced production of proinflammatory cytokines and chemokines (TNF‐α, IFN‐γ, CCL2, CCL3, and CCL5) and reduced infiltration of CD8+, CD4+, and CD11c+ cells in the small intestine. Mechanistically, in addition to decreasing production of proinflammatory mediators, absence or pharmacological blockade of PI3Kγ was associated with decreased rolling and adhesion of leukocytes to the mesenteric microcirculation, as assessed by intravital microscopy. Despite decreased GVHD, there was maintained GVL activity when PI3Kγ−/− leukocytes were transferred into WT mice. In conclusion, PI3Kγ plays a critical role in GVHD by mediating leukocyte influx and activation in tissues. PI3Kγ inhibitors may be useful in the treatment of GVHD in patients undergoing BMT.


Psychopharmacology | 2014

Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial

Andre R. Brunoni; Rodrigo Machado-Vieira; Carlos A. Zarate; Leandro Valiengo; Érica Leandro Marciano Vieira; Isabela M. Benseñor; Paulo A. Lotufo; Wagner F. Gattaz; Antônio Lúcio Teixeira

RationaleThe inflammatory hypothesis of depression states that increased levels of pro-inflammatory cytokines triggered by external and internal stressors are correlated to the acute depressive state. This hypothesis also suggests that pharmacotherapy partly acts in depression through anti-inflammatory effects. Transcranial direct current stimulation (tDCS) is a novel, promising, non-invasive somatic treatment for depression, although its antidepressant mechanisms are only partly understood.ObjectivesWe explored the effects of tDCS and sertraline over the immune system during an antidepressant treatment trial.MethodsIn a 6-week, double-blind, placebo-controlled trial, 73 antidepressant-free patients with unipolar depression were randomized to active/sham tDCS and sertraline/placebo (2 × 2 design). Plasma levels of several cytokines (IL-2, IL-4, IL-6, IL-10, IL-17a, IFN-γ, and TNF-α) were determined to investigate the effects of the interventions and of clinical response on them.ResultsAll cytokines, except TNF-α, decreased over time, these effects being similar across the different intervention-groups and in responders vs. non-responders.ConclusionstDCS and sertraline (separately and combined) acute antidepressant effects might not specifically involve normalization of the immune system. In addition, being one of the first placebo-controlled trials measuring cytokines over an antidepressant treatment course, our study showed that the decrease in cytokine levels during the acute depressive episode could involve a placebo effect, highlighting the need of further placebo-controlled trials and observational studies examining cytokine changes during depression treatment and also after remission of the acute depressive episode.


Progress in Neuro-psychopharmacology & Biological Psychiatry | 2015

Assessment of non-BDNF neurotrophins and GDNF levels after depression treatment with sertraline and transcranial direct current stimulation in a factorial, randomized, sham-controlled trial (SELECT-TDCS): An exploratory analysis

Andre R. Brunoni; Rodrigo Machado-Vieira; Carlos A. Zarate; Érica Leandro Marciano Vieira; Leandro Valiengo; Isabela M. Benseñor; Paulo A. Lotufo; Wagner F. Gattaz; Antônio Lúcio Teixeira

The neurotrophic hypothesis of depression states that the major depressive episode is associated with lower neurotrophic factors levels, which increase with amelioration of depressive symptoms. However, this hypothesis has not been extended to investigate neurotrophic factors other than the brain-derived neurotrophic factor (BDNF). We therefore explored whether plasma levels of neurotrophins 3 (NT-3) and 4 (NT-4), nerve growth factor (NGF) and glial cell line derived neurotrophic factor (GDNF) changed after antidepressant treatment and correlated with treatment response. Seventy-three patients with moderate-to-severe, antidepressant-free unipolar depression were assigned to a pharmacological (sertraline) and a non-pharmacological (transcranial direct current stimulation, tDCS) intervention in a randomized, 2 × 2, placebo-controlled design. The plasma levels of NT-3, NT-4, NGF and GDNF were determined by enzyme-linked immunosorbent assay before and after a 6-week treatment course and analyzed according to clinical response and allocation group. We found that tDCS and sertraline (separately and combined) produced significant improvement in depressive symptoms. Plasma levels of all neurotrophic factors were similar across groups at baseline and remained significantly unchanged regardless of the intervention and of clinical response. Also, baseline plasma levels were not associated with clinical response. To conclude, in this 6-week placebo-controlled trial, NT-3, NT-4, NGF and GDNF plasma levels did not significantly change with sertraline or tDCS. These data suggest that these neurotrophic factors are not surrogate biomarkers of treatment response or involved in the antidepressant mechanisms of tDCS.

Collaboration


Dive into the Érica Leandro Marciano Vieira's collaboration.

Top Co-Authors

Avatar

Antônio Lúcio Teixeira

Universidade Federal de Minas Gerais

View shared research outputs
Top Co-Authors

Avatar

Natália Pessoa Rocha

Universidade Federal de Minas Gerais

View shared research outputs
Top Co-Authors

Avatar

Izabela Guimarães Barbosa

Universidade Federal de Minas Gerais

View shared research outputs
Top Co-Authors

Avatar

Adriana Maria Kakehasi

Universidade Federal de Minas Gerais

View shared research outputs
Top Co-Authors

Avatar

Ana Cristina Simões e Silva

Universidade Federal de Minas Gerais

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mauro M. Teixeira

Universidade Federal de Minas Gerais

View shared research outputs
Top Co-Authors

Avatar

Aline Silva de Miranda

Universidade Federal de Minas Gerais

View shared research outputs
Top Co-Authors

Avatar

Nayara Felicidade Tomaz Braz

Universidade Federal de Minas Gerais

View shared research outputs
Top Co-Authors

Avatar

Vanessa Amaral Mendonça

Universidade Federal de Minas Gerais

View shared research outputs
Researchain Logo
Decentralizing Knowledge